Abstract:Background Epithelial-mesenchymal transition (EMT) is a crucial step for solid tumor progression and plays an important role in cancer invasion and metastasis. RNF8 is an ubiquitin E3 ligase with RING domain, and plays essential roles in DNA damage response and cell cycle regulation. However the role of RNF8 in the pathogenesis of breast cancer is still unclear. Methods The expression of RNF8 was examined in different types of breast cell lines by Western Blotting. EMT associated markers were examined by Immunofluorescence and Western Blotting in MCF-7 when RNF8 was ectopically overexpressed, or in MDA-MB-231 when RNF8 was depleted. Transwell and wound healing assays were performed to assess the effect of RNF8 on cell mobility. The xenograft model was done with nude mice to investigate the role of RNF8 in tumor metastasis in vivo. Breast tissue arrays were used to examine the expression of RNF8 by immunohistochemistry. Kaplan-Meier survival analysis for the relationship between survival time and RNF8 signature in breast cancer was done with an online tool ( http://kmplot.com/analysis/ ). Results RNF8 is overexpressed in highly metastatic breast cancer cell lines. Overexpression of RNF8 in MCF-7 significantly promoted EMT phenotypes and facilitated cell migration. On the contrary, silencing of RNF8 in MDA-MB-231 induced MET phenotypes and inhibited cell migration. Furthermore, we proved that these metastatic behavior promoting effects of RNF8 in breast cancer was associated with the inactivation of GSK-3β and activation of β-catenin signaling. With nude mice xenograft model, we found that shRNA mediated-downregulation of RNF8 reduced tumor metastasis in vivo. In addition, we found that RNF8 expression was higher in malignant breast cancer than that of the paired normal breast tissues, and was positively correlated with lymph node metastases and poor survival time. Conclusions RNF8 induces EMT in the breast cancer cells and promotes breast cancer metastasis, suggesting that RNF8 could be used as a potential therapeutic target for the prevention and treatment of breast cancer.

RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage

RNF8 Promotes Lung Cancer Tumorigenesis and Chemoresistance by Regulating AKT

RNF8 Depletion Attenuates Hepatocellular Carcinoma Progression by Inhibiting Epithelial-Mesenchymal Transition and Enhancing Drug Sensitivity

RNF8 Depletion Attenuates Hepatocelluar Carcinoma Progression by Inhibiting Epithelial Mesenchymal Transition and Enhancing Drug Sensitivity

RNF8 Promotes Epithelial–Mesenchymal Transition in Lung Cancer Cells Via Stabilization of Slug

RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation

RNF8 Promotes Epithelial-Mesenchymal Transition of Breast Cancer Cells

LRF Maintains Genome Integrity by Regulating the Non-Homologous End Joining Pathway of DNA Repair

Interplay Of Mkp-1 And Nrf2 Drives Tumor Growth And Drug Resistance In Non-Small Cell Lung Cancer

Genome-wide Global Identification of NRF2 Binding Sites in A549 Non-Small Cell Lung Cancer Cells by ChIP-Seq Reveals NRF2 Regulation of Genes Involved in Focal Adhesion Pathways

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.

RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination

Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1.

KLF8 Promotes the Survival of Lung Adenocarcinoma During Nutrient Deprivation by Regulating the Pentose Phosphate Pathway through SIRT2

NRF2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway

RNF8 Mediates Histone H3 Ubiquitylation and Promotes Glycolysis and Tumorigenesis

The Crtc1-Nedd9 Signaling Axis Mediates Lung Cancer Progression Caused By Lkb1 Loss

Data from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by <i>LKB1</i> Loss

Direct Binding of RNF8 to SUMO2/3 Promotes Cell Survival Following DNA Damage.

CDK16 Phosphorylates and Degrades P53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer.